__NUXT_JSONP__("/drugs/Ropocamptide", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:b,chebiId:b,chemicalFormula:b,definition:"A synthetic form of a human antimicrobial peptide (37 amino acids), belonging to the cathelicidin family, with antimicrobial, anti-inflammatory, immunostimulating and potential antineoplastic activities. Upon intratumoral injection of the ropocamptide, this peptide increases p53 expression, and induces phosphatidylserine externalization, DNA fragmentation, cell cycle arrest and caspase-independent apoptosis-inducing factor (AIF)\u002F endonuclease G (EndoG)-mediated apoptotic cell death in susceptible cancer cells. This suppresses tumor cell proliferation.  LL-37, a protein secreted by bone marrow cells, circulating leukocytes, and various epithelial tissues, plays a crucial role in the innate host immune defense via the regulation of leukocyte chemotaxis and cytokine production; it also promotes wound healing.",fdaUniiCode:"3DD771JO2H",identifier:"C118292",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129820","C129821"],synonyms:["Antimicrobial Peptide, Human LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES","Cathelicidin LL-37","LL-37","ROPOCAMPTIDE",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FRopocamptide",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Ropocamptide","","2021-10-30T13:19:40.503Z")));